HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemoglobin Yakina. I. Clinical and biochemical studies.

Abstract
Three members of a family who have erythrocytosis and a new hemoglobin, designated hemoglobin Yakima, are described. The abnormal hemoglobin is characterized by the substitution of histidine for aspartic acid at residue 99 in the beta-chain. Of three possible structure-function relations which would account for the increased oxygen affinity of hemoglobin Yakima, only two seem likely. These are: (a) an intrachain shift in the normal relations between the F and G helices and the heme group, or (b) an effect of the substituted side chain at a region of contact between nonpolar residues of the alpha- and beta-chains which favors the oxyhemoglobin quarternary structure.
AuthorsR T Jones, E E Osgood, B Brimhall, R D Koler
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 46 Issue 11 Pg. 1840-7 (Nov 1967) ISSN: 0021-9738 [Print] United States
PMID6061751 (Publication Type: Journal Article)
Chemical References
  • Hemoglobins, Abnormal
  • Aspartic Acid
  • Histidine
Topics
  • Aspartic Acid
  • Female
  • Hemoglobins, Abnormal (analysis)
  • Histidine
  • Humans
  • Polycythemia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: